Agreed. How you do your purchases largely depends on how much capital you have and your risk tolerance.
In this case, obviously with this company's quality, liquidity, track record and growth prospects, I can allocate more capital than most of my usual purchases.
However, I am wary of the valuation. 30x earnings for such a large, relatively mature company (growing the bottom line in the low double digits) at this stage in the market cycle is still rich, hence I am cautious even at $170.
CSL Chart, page-366
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$277.01 |
Change
-7.040(2.48%) |
Mkt cap ! $134.1B |
Open | High | Low | Value | Volume |
$280.67 | $281.07 | $275.01 | $254.8M | 915.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1140 | $277.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$277.08 | 312 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 465 | 277.000 |
2 | 183 | 276.500 |
1 | 15 | 276.450 |
1 | 84 | 276.150 |
5 | 168 | 276.000 |
Price($) | Vol. | No. |
---|---|---|
277.490 | 340 | 1 |
277.500 | 500 | 1 |
277.570 | 6 | 1 |
277.850 | 200 | 1 |
278.000 | 50 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online